A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures

Epilepsy Research

Volumn 91, Issue 1, 2010, Pages 10-19

  Baulac, Michel ^a   Leon, Teresa ^b   O'Brien, Terence J ^c   Whalen, Edward ^b   Barrett, Jeannette ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b PFIZER INC   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antiepileptic drugs; Lamotrigine; Placebo; Pregabalin; Randomized; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE PLUS LEVETIRACETAM; CARBAMAZEPINE PLUS TOPIRAMATE; CLOBAZAM; IBUPROFEN; LAMOTRIGINE; PARACETAMOL; PLACEBO; PREGABALIN; UNCLASSIFIED DRUG;

ABNORMAL THINKING; ACCIDENTAL INJURY; ADOLESCENT; ADULT; AGED; AMBLYOPIA; ARTICLE; ASTHENIA; ATAXIA; BRAIN DISEASE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INFECTION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; VERTIGO; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIZZINESS; DOUBLE-BLIND METHOD; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PLACEBO EFFECT; SEIZURES; TRIAZINES; WEIGHT GAIN; YOUNG ADULT;

EID: 77956059743     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2010.05.008     Document Type: Article

References (19)

1. Arroyo S., Anhut H., Kugler A.R., Lee C.M., Knapp L.E., Garofalo E.A., Messmer S. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004, 45:20-27.
2. Beydoun A., Uthman B.M., Kugler A.R., Greiner M.J., Knapp L.E., Garofalo E.A. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 2005, 64:475-480.
3. Biton V., Sackellares J.C., Vuong A., Hammer A.E., Barrett P.S., Messenheimer J.A. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 2005, 65:1737-1743.
4. Brodie M.J., Wilson E.A., Wesche D.L., Alvey C.W., Randinitis E.J., Posvar E.L., Hounslow N.J., Bron N.J., Gibson G.L., Bockbrader H.N. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 2005, 46:1407-1413.
5. Elger C.E., Brodie M.J., Anhut H., Lee C.M., Barrett J.A. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 2005, 46:1926-1936.
6. Fleiss J.L. Statistical Methods for Rates and Proportions 1981, Wiley Interscience, New York, NY.
7. French J.A., Kugler A.R., Robbins J.L., Knapp L.E., Garofalo E.A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 2003, 60:1631-1637.
8. Gilliam F., Vazquez B., Sackellares J.C., Chang G.Y., Messenheimer J., Nyberg J., Risner M.E., Rudd G.D. An active-control trial of lamotrigine monotherapy for partial seizures. Neurology 1998, 51:1018-1025.
9. GlaxoSmithKline (2007). LAMICTAL® (lamotrigine) Tablets [prescribing information], Research Triangle Park, NC.
10. Jawad S., Richens A., Goodwin G., Yuen W.C. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989, 30:356-363.
11. LaRoche S.M., Helmers S.L. The new antiepileptic drugs: scientific review. JAMA 2004, 291:605-614.
12. Lindberger M., Alenius M., Frisen L., Johannessen S.I., Larsson S., Malmgren K., Tomson T. Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatment. Epilepsia 2000, 41:1289-1295.
13. Marson A.G., Al-Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W., Cramp C., Cockerell O.C., Cooper P.N., Doughty J., Eaton B., Gamble C., Goulding P.J., Howell S.J.L., Hughes A., Jackson M., Jacoby A., Kellett M., Lawson G.R., Leach J.P., Nicolaides P., Roberts R., Shackley P., Shen J., Smith D.F., Smith P.E.M., Smith C.T., Vanoli A., Williamson P.R. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007, 369:1016-1026.
14. Marson A.G., Williamson P.R., Clough H., Hutton J.L., Chadwick D.W. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 2002, 43:505-513.
15. Matsuo F., Bergen D., Faught E., Messenheimer J.A., Dren A.T., Rudd G.D., Lineberry C.G. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology 1993, 43:2284-2291.
16. Messenheimer J., Ramsay R.E., Willmore L.J., Leroy R.F., Zielinski J.J., Mattson R., Pellock J.M., Valakas A.M., Womble G., Risner M. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994, 35:113-121.
17. Ryvlin P. Defining success in clinical trials - profiling pregabalin, the newest AED. Eur. J. Neurol. 2005, 12(Suppl. 4):12-21.
18. Steel R.G., Torrie J.H. Principles and Procedures of Statistics 1960, McGraw-Hill Companies, New York, NY.
19. Taylor C.P., Angelotti T., Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007, 73:137-150.